as on September 17, 2025 at 1:23 am IST
Day's Low
Day's High
1.23%
Downside
6.17%
Upside
52 Week's Low
52 Week's High
27.16%
Downside
961.73%
Upside
Check Lakeshore Biopharma Co Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$33.2M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Lakeshore Biopharma Co Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $33.2M | NA | NA | -16.26% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Lakeshore Biopharma Co Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lakeshore Biopharma Co Ltd investment value today
Current value as on today
₹14,838
Returns
Returns from Lakeshore Biopharma Co Ltd Stock
Dollar Returns*
₹4,598 (+4.6%)
Search interest for Lakeshore Biopharma Co Ltd Stock has increased by 900% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:900% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 157.9%
Revenue Fall
Revenue is down for the last 2 quarters, 168.70M → 135.52M (in $), with an average decrease of 19.7% per quarter
Price Dip
In the last 6 months, LSB stock has moved down by -61.8%
Profit Down
Netprofit is down for the last 2 quarters, -80.15M → -181.41M (in $), with an average decrease of 126.3% per quarter
Organisation | Lakeshore Biopharma Co Ltd |
Headquarters | Building No. 2, Beijing, China, 102629 |
CEO | Mr. Wang Xu |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Rui Yu M.B.A., M.S. | CFO & Director |
Ms. Zhiyuan Ran | Head of Marketing and Sales |
Dr. Honggang Teng | Head of Production & Quality Management |
Dr. Yuan Liu Ph.D. | Head of Vaccine Research |
Mr. Wang Xu | CEO & Director |
Dr. Hui Shao C.F.A., M.B.A., Ph.D. | President, Chief Business Officer & Vice Chairman |
Lakeshore Biopharma Co Ltd share price today is $0.81 as on at the close of the market. Lakeshore Biopharma Co Ltd share today touched a day high of $0.86 and a low of $0.8.
Lakeshore Biopharma Co Ltd share touched a 52 week high of $8.6 on and a 52 week low of $0.59 on . Lakeshore Biopharma Co Ltd stock price today i.e. is closed at $0.81,which is 90.58% down from its 52 week high and 37.29% up from its 52 week low.
Lakeshore Biopharma Co Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Lakeshore Biopharma Co Ltd (LSB) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Lakeshore Biopharma Co Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lakeshore Biopharma Co Ltd share’s latest price of $0.81 as on September 17, 2025 at 1:23 am IST, you will get 12.3457 shares of Lakeshore Biopharma Co Ltd. Learn more about
fractional shares .